Furthermore, FTO has been found to have a significant impact on vascular function, including inhibiting the release of vascular endothelial growth factor and angiogenesis, counteracting metabolic and vascular dysfunction caused by obesity, and inducing proliferation and inflammatory response of vascular smooth muscle cells42–44. Here, VEGFA is linked to obesity due to melanocortin 4 receptor deficiency.